Navigation Links
First Multiple Dose Clinical Trial of TorreyPines Therapeutics' Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated
Date:2/11/2009

als will be reported within the anticipated timeframe, that NGX426 will successfully treat migraine, neuropathic pain and/or other indications for which it is developed, or that TorreyPines will be able to complete the necessary development work and receive regulatory approval for NGX426. These and other risks which may cause results to differ are described in greater detail in the "Risk Factors" section of TorreyPines' annual report on Form 10-K for the year ended December 31, 2007 and TorreyPines other SEC reports. The forward-looking statements are based on current information that is likely to change and speak only as of the date hereof.

    Company contact:
    Paul Schneider
    TorreyPines Therapeutics, Inc.
    (858) 623-5665 x125
    pschneider@tptxinc.com

    Investor contact:
    Rhonda Chiger
    Rx Communications Group
    (917) 322-2569
    rchiger@rxir.com


'/>"/>
SOURCE TorreyPines Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Max Muscle Introduces First-Ever Probiotics Protein Bar
2. Pharmasset Reports Fiscal First Quarter 2009 Financial Results
3. Hoya Announces Third Quarter and the First Nine Months Financial Results for FY2008
4. Historic Seed Delivery Made in Illinois for First New Soybean Varieties With the Greater Yield Potential of Roundup Ready 2 Yield(TM)
5. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study
6. World's First Website for Patients to Share Diagnostic-Quality Medical Images
7. Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the Worlds First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop
8. BioComp Pharma Launches First Generic Drug for Tindamax(R)
9. deCODE Discovers First Genetic Variant Conferring Increased Risk of Essential Tremor
10. Complete Genomics to Release Its DNA Sequencing Data for the First Time at Advances in Genome Biology and Technology Annual Meeting
11. AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... deicing film for radar domes have now refined the ... , The new work by Rice chemist James ... windshields to skyscrapers free of ice and fog while ... The technology was introduced this month in the American ... , The material is made of graphene nanoribbons, ...
(Date:9/16/2014)... MILLBROOK, N.Y. , Sept. 16, 2014  Donald Fresne, ... the appointment of Stephan Vagner , PhD to its ... the University of Toulouse, France , performed ... Germany , and at Inserm, the French institute of ... Inserm and works both at the Curie Institute, Orsay, ...
(Date:9/16/2014)... Md. , Sept. 16, 2014   ... biotechnology company developing novel anti-infective biologic and drug ... and diseases, announced today the completion of the Company,s ... which highlighted its irritable bowel syndrome (IBS) ... constipation-predominant IBS (C-IBS). In the keynote ...
(Date:9/16/2014)... 16, 2014  LABSCO, the leading specialty sales ... hospitals, physician office laboratories and alternate healthcare settings ... 2014, it will serve as Siemens Healthcare Diagnostics, ... and as a semi-exclusive sales distributor in specified ... United States . LABSCO will be ...
Breaking Biology Technology:Nanoribbon film keeps glass ice-free 2New Appointment to the Scientific Advisory Committee at Egenix, Inc. 2Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day 2Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day 3LABSCO Secures Alliance With Siemens Healthcare Diagnostics 2LABSCO Secures Alliance With Siemens Healthcare Diagnostics 3
... 25 Codexis, Inc., today,announced the appointment of ... President, Bioindustrials Research and Development. He,joins Codexis from ... will,report to Alan Shaw, Ph.D., President and CEO., ... markets where,clean technology can make a significant impact," ...
... Derma Sciences,Inc. (OTC Bulletin Board: DSCI), a ... MEDIHONEY(TM) Wound & Burn Dressing, its,flagship wound care ... news health segments., Washington NBC affiliate News ... evaluating MEDIHONEY for wound care., http://video.nbc4.com/player/?id=231798 , ...
... Medivation, Inc.,(Nasdaq: MDVN ) today announced ... president, regulatory and quality, Mohammad Hirmand, M.D., to ... vice,president, translational medicine., "As we enter Phase ... are,strengthening the team to lead and advance our ...
Cached Biology Technology:Codexis Names David Anton VP Bioindustrials R&D 2Derma Sciences' MEDIHONEY(TM) Profiled in Several Television News Health Reports 2Medivation Announces Senior Management Promotions 2Medivation Announces Senior Management Promotions 3
(Date:9/15/2014)... that lowland tapir populations may continue to drop in ... from the Office National de la Chasse et de ... Zoo Global reviewed data retrieved from camera traps in ... and compared this data to current harvest rates in ... tapirs in French Guiana," said Matthias Tobler, a scientist ...
(Date:9/15/2014)... Adding a common epilepsy drug to a morphine regimen ... effects. Moreover, the combination can reduce the dosage of ... team of pain researchers at Indiana University. , The ... neuropathic pain, a difficult-to-treat condition often felt in the ... , "There is a huge unmet need for better ...
(Date:9/15/2014)... a vital source of energy for both plants and ... way into the cell could lead to the design ... in the amount of fruits and vegetables farmers are ... one of these "pathways" into the cell by piecing ... strand of spider silk. , To determine the size, ...
Breaking Biology News(10 mins):IU study: Combining epilepsy drug, morphine can result in less pain, lower opioid doses 2X-rays unlock a protein's SWEET side 2X-rays unlock a protein's SWEET side 3
... cells communicate with each other by means of electrical ... charged ions with their environment. However, the role played ... theories predicted a relation between the chloride channel ClC-2 ... Neurobiology in Martinsried were now able to confirm a ...
... The International Osteoporosis Foundation (IOF) invites you ... Meeting to be held in Singapore from December ... www.iofbonehealth.org/singapore2010 The scientific programme will provide ... latest information on prevention, diagnosis and treatment of ...
... (Baltimore, MD) Kennedy Krieger Institute announced today new ... appear in the first three years of life has ... outcomes. Published this month in the Journal of ... this study found children with early developmental warning signs ...
Cached Biology News:Chloride channels render nerve cells more excitable 2Chloride channels render nerve cells more excitable 3Register now for the IOF Regionals -- 1st Asia-Pacific Osteoporosis Meeting 2Study provides new insights into the implications of autism onset patterns 2Study provides new insights into the implications of autism onset patterns 3
Mouse monoclonal [3G8] to MDMA ( Abpromise for all tested applications)....
Shh Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Anti-Cohesin (Scc1/Rad21) Monoclonal Antibody Research Focus: signal transduction Storage: -20C Shipping Temperature: +4C...
... to Asparagine synthetase ( Abpromise ... Antigen: ... in the C-terminus of Human ... Entrez GeneID: 440 ...
Biology Products: